Dvida tells readers, on the page selling them, that two of the compounds it lists appear on the regulator's bulk drug substances warning list and are not approved for human use.
By Nora Castellan, Standards EditorUpdated September 2026
A seller naming the regulator's own list against its own menu
The note sits on the peptide page, directly above the catalogue. It names two compounds this site tracks, says they appear on the regulator's bulk drug substances warning list, and says they are not approved for human use.
It then continues to sell them, under prescription, and says so: peptides are prescribed by qualified clinicians and dispensed by registered compounding pharmacies.
Its FAQ makes the same point without hedging — asked whether peptides are approved, it answers no, and explains that they are compounded medications.
That combination is rare. Most sellers of those two compounds either do not mention the list or mention it in a way that implies it does not apply to them.
Named company, no prices
The terms open by naming the operating company, and the same name recurs in the services overview and in the messaging clauses, so it is unambiguous rather than a footer tail.
The joined text of the peptide page and the terms carries no dollar amount at all. Nine compounds this site tracks are named and none has a figure.
No dispensing pharmacy is named and no state coverage is published, although the clinic operates in two places.
A spelling error in the address
The seller's own product URL misspells the word therapy, and it repeats the same misspelling on its second location's page.
That is trivial until someone retypes the address correctly and gets a not-found. It is recorded so that a later reader does not "fix" a link into a broken one.
No certificate or testing document is claimed anywhere on the pages read.
Who it's for
Readers who want a seller to name the regulator's own list against its own menu.
Buyers who want a plain no to the approval question.
Anyone who wants the operating company named in the first line of the terms.
Shoppers near either of its two locations.
Who should look elsewhere
Anyone comparing prices — none is published.
Readers who need the dispensing pharmacy named.
Buyers who need state coverage.
Shoppers who want depth behind each compound rather than a listing.
Strengths
Names the FDA bulk substances warning list against two compounds on its own menu, on the page selling them
Answers "are peptides FDA-approved" with the word "No" and then explains
Names its operating company in the first line of its terms
Distinguishes compounded GLP-1s from branded products in the same note
Trade-offs
Publishes no price for anything
Publishes no state coverage and names no dispensing pharmacy
Its own product URL carries a spelling error that a reader retyping the address will not reproduce
The disclosure is strong but the catalogue detail behind each compound is thin
How we verified this
Fetched the peptide page and the terms of service with a full browser user-agent, comparing the effective URL to the requested one on both.
Fired a nonsense-path control at the host in the same run; it returned an honest not-found status despite a large body, so status and never size was read.
Joined the text nodes before matching and confirmed neither page carries a dollar amount.
Read the bulk-substances note in full, including which compounds it names.
Read the approval answer out of the seller's own FAQ rather than paraphrasing it.
Recorded the misspelling in the seller's own product path, and used the misspelled path rather than a corrected one.
Screened the operating company against the regulator's live warning-letter index, with a known-positive and a nonsense control in the same run.
A provider to compare Dvida Spa against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
That two compounds it lists appear on the bulk drug substances warning list and are not approved for human use, in a note directly above its catalogue.
Does it still sell them?
Yes, under prescription, dispensed by registered compounding pharmacies, and it says so in the same passage.
Are prices published?
No. Neither page read carries a dollar amount.
Is a company named?
Yes, in the opening line of its terms and repeatedly thereafter.
Is there anything odd about the address?
Yes. The seller's own product URL misspells the word therapy, on both of its location pages. Correcting it produces a not-found.
Dvida Spa is not a paid partner; this link may earn a commission if that changes. Full disclosure.